Adverse Effects of Combined Tyrosine Kinase Inhibitors

被引：0
|
作者：
Lu, Shun [1 ]
Li, Ziming [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 11期
关键词：
INTERSTITIAL LUNG-DISEASE; CANCER; C797S; GEFITINIB; T790M;
D O I：
10.1016/j.jtho.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E182 / E183
页数：2
相关论文
共 50 条
  • [31] Tyrosine kinase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (01) : 40 - 40
  • [32] Tyrosine Kinase Inhibitors
    Natoli, C.
    Perrucci, B.
    Perrotti, F.
    Falchi, L.
    Iacobelli, S.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (05) : 462 - 483
  • [33] Tyrosine kinase inhibitors
    Robert, Jacques
    BULLETIN DU CANCER, 2011, 98 (11) : 1321 - 1334
  • [34] Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors
    Zhou, F.
    Yang, Y.
    Zhang, L.
    Cheng, Y.
    Han, B.
    Lu, Y.
    Wang, C.
    Wang, Z.
    Yang, N.
    Fan, Y.
    Wang, L.
    Ma, Z.
    Zhang, L.
    Yao, Y.
    Zhao, J.
    Dong, X.
    Zhu, B.
    Zhou, C.
    ESMO OPEN, 2023, 8 (03)
  • [35] EFFECTS OF TYROSINE KINASE INHIBITORS ON PROTEIN KINASE-INDEPENDENT SYSTEMS
    YOUNG, SW
    POOLE, RC
    HUDSON, AT
    HALESTRAP, AP
    DENTON, RM
    TAVARE, JM
    FEBS LETTERS, 1993, 316 (03): : 278 - 282
  • [36] CLASS EFFECTS OF TYROSINE KINASE INHIBITORS ON OSTEOCLASTOGENESIS IN VITRO
    Mayr, G.
    Blueml, S.
    Puchner, T.
    Superti-Furga, G.
    Smolen, J.
    Redlich, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [37] Managing Side Effects from Tyrosine Kinase Inhibitors
    Fraser, Anne
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S157 - S157
  • [38] Side effects of tyrosine kinase inhibitors - management guidelines
    Pluzanski, Adam
    Piorek, Aleksandra
    ONCOLOGY IN CLINICAL PRACTICE, 2016, 12 (04): : 113 - 118
  • [39] Side effects of tyrosine kinase inhibitors in cancer treatment
    Mencinger, Marina
    ONKOLOGIJA, 2018, 22 (01) : 24 - 27
  • [40] Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia
    Rea, Delphine
    ANNALS OF HEMATOLOGY, 2015, 94 : S149 - S158
12345